LENVOVIQ Trademark
Trademark Overview
On Tuesday, November 28, 2023, a trademark application was filed for LENVOVIQ with the United States Patent and Trademark Office. The USPTO has given the LENVOVIQ trademark a serial number of 98288762. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, August 8, 2024. This trademark is owned by Gilead Sciences Ireland UC. The LENVOVIQ trademark is filed in the Pharmaceutical Products category with the following description:
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
General Information
| Serial Number | 98288762 |
| Word Mark | LENVOVIQ |
| Filing Date | Tuesday, November 28, 2023 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Thursday, August 8, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 22, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Gilead Sciences Ireland UC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Carrigtohill, Co. Cork
IE |
Trademark Events
| Event Date | Event Description |
| Friday, December 1, 2023 | NEW APPLICATION ENTERED |
| Wednesday, June 26, 2024 | ASSIGNED TO EXAMINER |
| Thursday, August 8, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, August 8, 2024 | LETTER OF SUSPENSION E-MAILED |
| Monday, January 22, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 8, 2024 | SUSPENSION LETTER WRITTEN |
| Monday, November 18, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
